BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33728499)

  • 1. [
    Kratochwil C; Giesel FL; Rathke H; Fink R; Dendl K; Debus J; Mier W; Jäger D; Lindner T; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):3011-3013. PubMed ID: 33728499
    [No Abstract]   [Full Text] [Related]  

  • 2. High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma.
    Franzius C; Bielack S; Sciuk J; Vollet B; Jürgens H; Schober O
    Nuklearmedizin; 1999; 38(8):337-40. PubMed ID: 10615669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated [
    Liu H; Wang Y; Zhang W; Cai L; Chen Y
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1671-1672. PubMed ID: 33184681
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated 68Ga-FAPI Accumulation in a Recurrent Angiomyolipoma.
    Qin C; Gai Y; Liu Q; Shao F; Lan X
    Clin Nucl Med; 2020 Dec; 45(12):1034-1035. PubMed ID: 33086278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutron Activated
    Wang JT; Klippstein R; Martincic M; Pach E; Feldman R; Šefl M; Michel Y; Asker D; Sosabowski JK; Kalbac M; Da Ros T; Ménard-Moyon C; Bianco A; Kyriakou I; Emfietzoglou D; Saccavini JC; Ballesteros B; Al-Jamal KT; Tobias G
    ACS Nano; 2020 Jan; 14(1):129-141. PubMed ID: 31742990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events in the long-term follow-up of patients treated with samarium Sm 153 lexidronam for osseous metastases.
    Paravati AJ; Russo AL; Aitken C
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):506-10. PubMed ID: 20888141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of
    Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
    Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-FAPI PET/CT in Assessment of Leptomeningeal Metastases in a Patient With Lung Adenocarcinoma.
    Hao B; Wu J; Pang Y; Sun L; Chen H
    Clin Nucl Med; 2020 Oct; 45(10):784-786. PubMed ID: 32796242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223.
    Anderson PM; Subbiah V; Rohren E
    Adv Exp Med Biol; 2014; 804():291-304. PubMed ID: 24924181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
    Anderson P; Nuñez R
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1517-27. PubMed ID: 18020921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
    Anderson PM; Wiseman GA; Dispenzieri A; Arndt CA; Hartmann LC; Smithson WA; Mullan BP; Bruland OS
    J Clin Oncol; 2002 Jan; 20(1):189-96. PubMed ID: 11773169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INDUCTION AND TRANSPLANTATION OF CANCER OF THE LUNG IN RATS.
    MORI K
    Gan; 1963 Dec; 54():415-25. PubMed ID: 14099938
    [No Abstract]   [Full Text] [Related]  

  • 13. Low toxicity and efficacy of (153)samarium-EDTMP and melphalan as a conditioning regimen for secondary acute myelogenous leukemia.
    Rodriguez V; Erlandson L; Arndt CA; Wiseman GA; Anderson PM
    Pediatr Transplant; 2005 Feb; 9(1):122-6. PubMed ID: 15667625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-lung irradiation in the treatment of metastatic synovial sarcoma.
    Gerber NK; Meyers PA; LaQuaglia MP; Wolden SL
    Pediatr Blood Cancer; 2014 Nov; 61(11):2092-3. PubMed ID: 24939451
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kratochwil C; Flechsig P; Lindner T; Abderrahim L; Altmann A; Mier W; Adeberg S; Rathke H; Röhrich M; Winter H; Plinkert PK; Marme F; Lang M; Kauczor HU; Jäger D; Debus J; Haberkorn U; Giesel FL
    J Nucl Med; 2019 Jun; 60(6):801-805. PubMed ID: 30954939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.
    Sartor O; Reid RH; Bushnell DL; Quick DP; Ell PJ
    Cancer; 2007 Feb; 109(3):637-43. PubMed ID: 17167764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and pharmacokinetics of samarium(III)-153-labeled DTPA-bis-biotin. Characterization and theoretical studies of the samarium(III)-152 conjugate.
    Ferro-Flores G; Ramírez FD; Tendilla JI; Pimentel-González G; Murphy CA; Meléndez-Alafort L; Ascencio JA; Croft BY
    Bioconjug Chem; 1999; 10(5):726-34. PubMed ID: 10502337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung metastases of a neurinoplastic sarcoma presumably of the thyroid gland with a tendency to retrogression].
    de VEER
    Fortschr Geb Rontgenstr Nuklearmed; 1960 Dec; 93():796-8. PubMed ID: 13780567
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteogenic sarcoma. Sustained disappearance of pulmonary metastases after only palliative irradiation.
    FRANCIS KC; HUTTER RV; PHILLIPS RK; EYERLY RC; SCHECHTER L
    N Engl J Med; 1962 Apr; 266():694-9. PubMed ID: 13894511
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal treatment of painful bone metastases with Samarium EDTMP in a haemodialysis patient: effectiveness and safety of internal radiotherapy.
    Skalli S; Desruet MD; Bourre JC; Caravel JP; Vuillez JP
    Nephrol Dial Transplant; 2009 Aug; 24(8):2598-600. PubMed ID: 19369693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.